A team of American researchers from Stanford University has developed new viruses using artificial intelligence, as reported by Science and BBC. These viruses, designed to target bacteria like E. coli, represent the first time complete genomes have been created via AI, according to the researchers. The AI models, named Evo1 and Evo2, were trained on genetic codes of various organisms and generated 16 effective bacteriophages capable of killing E. coli in laboratory tests. While the scientists describe this as a significant breakthrough in medicine, experts warn of potential misuse, raising concerns about biosecurity and the risk of creating new pathogens. Researchers at Stanford emphasize safety measures, including excluding harmful viruses from training data and conducting experiments in secure labs. They argue that while malicious actors could potentially exploit the technology, existing pathogens pose a greater immediate threat.
Bias read (Center): The article presents balanced reporting on both the scientific advancements and the ethical concerns raised by experts. It does not take a clear ideological stance but rather reports on the dual implications of the research, potential medical benefits versus biosecurity risks. The framing remains non





